Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "infectious-diseases"

212 News Found

Thailand and GHIT Fund join forces to tackle infectious diseases
News | April 08, 2026

Thailand and GHIT Fund join forces to tackle infectious diseases

The collaboration promises expanded funding for Thai universities, research institutes, companies, and global research partners working in Thailand


75% of newly emerging infectious diseases over last three decades are zoonotic in nature: Union Health Secretary
Public Health | October 19, 2023

75% of newly emerging infectious diseases over last three decades are zoonotic in nature: Union Health Secretary

Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”


Thermo Fisher Scientific launches real-time PCR kits for detection of infectious diseases in India
Medical Device | February 15, 2023

Thermo Fisher Scientific launches real-time PCR kits for detection of infectious diseases in India

The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care


Plasma-based green disinfectants can limit spread of infectious diseases like Covid-19
News | April 20, 2022

Plasma-based green disinfectants can limit spread of infectious diseases like Covid-19

Researchers have developed a plasma-based disinfectant generated with the help of cold atmospheric pressure plasma (CAP) which could act as a green decontaminant for Covid-19


European Commission approves AbbVie's MAVIRET for acute Hepatitis C treatment
Drug Approval | June 24, 2026

European Commission approves AbbVie's MAVIRET for acute Hepatitis C treatment

Approval makes it the first and only therapy in the EU indicated for both acute and chronic hepatitis C, supported by Phase 3 data


FDA expands use of Merck’s CAPVAXIVE for high-risk children and teens
Drug Approval | June 21, 2026

FDA expands use of Merck’s CAPVAXIVE for high-risk children and teens

The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections


Moderna reshapes leadership and ops model as it pushes into oncology, rare disease
News | June 18, 2026

Moderna reshapes leadership and ops model as it pushes into oncology, rare disease

CEO Stéphane Bancel framed the changes as essential to scaling the business


Omnix Medical advances first-in-class antimicrobial OMN6 into Phase II trials
Medical Device | June 05, 2026

Omnix Medical advances first-in-class antimicrobial OMN6 into Phase II trials

Targeting deadly drug-resistant acinetobacter infections


Akums secures European CEP approval for Cefpodoxime Proxetil
Drug Approval | June 03, 2026

Akums secures European CEP approval for Cefpodoxime Proxetil

The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner


Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6
News | June 03, 2026

Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6

First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept